Since its inception in 2018, COLD-CE has collected data on hundreds of patients with cold urticaria from around the world. In this episode, Dr Mojca Bizjak reflects on her experience of running a UCARE project, offering insight and advice for those hoping to do so in the future.
Despite affecting up to 5% of the population, symptomatic dermographism remains understudied. Discover more about how our ability to diagnose and treat this common and debilitating condition is improving from urticaria expert, Dr Tomasz Hawro.
Dr Frank Siebenhaar brings us up to date on the differences between mastocytosis, urticaria and mast cell activation syndrome (MCAS). He also introduces CSUplus, an ongoing UCARE project that aims to shed light on the extracutaneous symptoms of chronic spontaneous urticaria.
Dr Jorge Sánchez reflects on how it felt to give himself urticaria and explains what his bold experiment has taught us about the role of anti-TPO IgE in this disease.
Angioedema expert and ACARE founding father, Professor Markus Magerl, joins Professor Marcus Maurer to discuss all things angioedema and get the latest on the ever-growing ACARE network.
Professor Marcus Maurer is joined by Dr Emek Kocatürk Göncü who addresses concerns regarding the impact of COVID-19 infection in patients with chronic urticaria and summarises the results of the recent UCARE project, PREG-CU.
Professor Martin Church reflects on the enormous progress that has been made in the field of urticariology and discusses what is yet to come for patients with this devastating disease.
This episode is for health care professionals only
Professor Marcus Maurer is joined by “UCARE father”, Dr Luis Felipe Ensina, to discuss the frequently underestimated burden of urticaria, which Dr Ensina explains is not limited to the patients themselves, but may indirectly impact numerous friends and family members as well.
With the sixth consensus meeting on the EAACI/GA2LEN/EDF/WAO guideline for urticaria fast approaching, Professor Marcus Maurer is joined by Professor Torsten Zuberbier, who explains what you can expect from this new edition.
This episode is intended for registered Healthcare Professionals only.
Cold urticaria expert, Dr Dorothea Terhorst-Molawi, and host, Professor Marcus Maurer, discuss the complexities of this highly heterogenous condition and explain why they are optimistic about what the future holds for those affected.
This episode is intended for registered Healthcare Professionals only.
20 min
About All Things Urticaria
From the publisher's feed
Catch up on ’All Things Urticaria’ in this podcast series developed by Global Allergy and Asthma Excellence Network UCARE in collaboration with Medthority. Professor Marcus Maurer, Professor of Dermatology and Allergy at Charité – Universitätsmedizin Berlin, is joined by colleagues for in-depth discussions on the latest research and opinion on the pathogenesis and treatment of urticaria. Medthority received educational funding from the sponsor to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated content. The opinions in this podcast are of the invited faculty, for informational purposes only, and should not be taken as medical advice. Please consult your regional guidelines for clinical practice recommendations in your area. For updates on ’All Things Urticaria’, sign up on Medthority. For more on UCARE/ACARE activities, visit the UCARE and ACARE websites, UCARE 4U, UDAY, CRUSE Control App, and CURE Registry.
Episodes 1 – 61: This content has been developed independently of the sponsor, Novartis Pharma AG.
Episode 31 and 33: This content has been in collaboration with J. Uriach y Compañía S.A.